Autism Disorder And Treatment Market Size, Share, Growth, Trends, and Forecast by 2031

Historic Data: 2021-2023   |   Base Year: 2024   |   Forecast Period: 2025-2031

Coverage: Autism Disorder And Treatment Market covers analysis By Type (Asperger Syndrome, Pervasive Developmental Disorder, Autistic Disorder); Mechanism of Action (Antipsychotics, Anticonvulsants, Antidepressants, Stimulants, Others); Therapy Type (Behavioral Therapy, Occupational Therapy, Physical Therapy, Speech Therapy, Others); Route of Administration (Oral, Intravenous, Others); End User (Hospitals, Homecare, Specialty Clinics, Others) , and Geography (North America, Europe, Asia Pacific, and South and Central America)

  • Report Code : TIPRE00007556
  • Category : Life Sciences
  • Status : Upcoming
  • No. of Pages : 150
Buy Now

MARKET OVERVIEW



Autism can also be termed as autism spectrum disorder (ASD), which refers to a wide-ranging about conditions characterized by challenges with repetitive behaviors, social skills, speech nonverbal communication and speech. It can occur in age of 2 or 3 and in treatment there are various trainings involved to improve the condition of a child is come under behavior and communication treatments such as discrete trial training, pivotal response training, early intensive behavioral intervention and others.

MARKET SCOPE



The "Global Autism Disorder And Treatment Market Analysis to 2031" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the autism disorder and treatment market with detailed market segmentation by procedure type, equipment, disease, end-user and geography. The report provides key statistics on the market status of the leading autism disorder and treatment market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION



  •   Based on type, the global autism disorder and treatment market is segmented into Asperger syndrome, Pervasive developmental disorder and autistic disorder.
  •   The mechanism of action segment is classified into antipsychotics, anticonvulsants, antidepressants, stimulants and others.
  •   Based on therapy type, the autism disorder and treatment market is segmented as behavioral therapy, occupational therapy, physical therapy, speech therapy and others.
  •   On the basis of route of administration, the market is segmented into oral, intravenous and others.
  •   On the basis of end-users the market is segmented into hospitals, homecare, specialty clinics, others

MARKET DYNAMICS


Drivers:



  •   Increasing number of autistic children
  •   Rising number of treatment centers
  •   Growing number of initiatives by government and NGOs to increase awareness about the disease

Restraints:



  •   Low awareness about the disease in developing countries

REGIONAL FRAMEWORK



The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The autism disorder and treatment market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the autism disorder and treatment market in these regions.

IMPACT OF COVID-19 ON Autism Disorder And Treatment MARKET



North American region is highly affected due to the outbreak of the Covid-19 pandemic. Countries such as the US and Canada reported the highest numbers of COVID-19 positive cases. The US-registered highest number of deaths due to the COVID-19 pandemic. The chaotic situation was created in the medical industry across the countries, increased demand for COVID diagnostics and therapeutics have dramatically increased in the hospitals. Additionally, Mexico and Canada cases are also rising. Due to coronavirus spreading, many cities are closing down, causing treatments and doctor's appointment cancellation. Patients with severe health conditions, such as neurological diseases and others; are witnessing delays in such chronic disease treatment.

MARKET PLAYERS



The report covers key developments in the autism disorder and treatment market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from autism disorder and treatment market are anticipated to lucrative growth opportunities in the future with the rising demand for autism disorder and treatment in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the autism disorder and treatment market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  •   AbbVie Inc.
  •   Johnson & Johnson Services
  •   GlaxoSmithKline plc
  •   F. Hoffmann-La Roche Ltd
  •   Eli Lilly
  •   Abbott
  •   Novartis AGP
  •   Intra-Cellular Therapies, Inc.
  •   Coronis Neurosciences Ltd.
  •   Sun Pharmaceutical Industries Ltd

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Autism Disorder And Treatment Report Scope

Report Attribute Details
Market size in 2024 US$ XX million
Market Size by 2031 US$ XX Million
Global CAGR (2025 - 2031) XX%
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By Type
  • Asperger Syndrome
  • Pervasive Developmental Disorder
  • Autistic Disorder
By Mechanism of Action
  • Antipsychotics
  • Anticonvulsants
  • Antidepressants
  • Stimulants
By Therapy Type
  • Behavioral Therapy
  • Occupational Therapy
  • Physical Therapy
  • Speech Therapy
By Route of Administration
  • Oral
  • Intravenous
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • AbbVie Inc.
  • Johnson & Johnson Services
  • GlaxoSmithKline plc
  • F. Hoffmann-La Roche Ltd
  • Eli Lilly
  • Abbott
  • Novartis AGP
  • Intra-Cellular Therapies, Inc.
  • Coronis Neurosciences Ltd.
    • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
    • PEST and SWOT Analysis
    • Market Size Value / Volume - Global, Regional, Country
    • Industry and Competitive Landscape
    • Excel Dataset
    autism-disorder-and-treatment-market-report-deliverables-img1
    autism-disorder-and-treatment-market-report-deliverables-img2
    Report Coverage

    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered

    Segment Covered

    This text is related
    to segments covered.

    Regional Scope

    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope

    Country Scope

    This text is related
    to country scope.

    Trends and growth analysis reports related to Life Sciences : READ MORE..   

    The List of Companies

    1. AbbVie Inc.
    2. Johnson & Johnson Services
    3. GlaxoSmithKline plc
    4. F. Hoffmann-La Roche Ltd
    5. Eli Lilly
    6. Abbott
    7. Novartis AGP
    8. Intra-Cellular Therapies, Inc.
    9. Coronis Neurosciences Ltd.
    10. Sun Pharmaceutical Industries Ltd
    autism-disorder-and-treatment-market-cagr